Sugi Predict

Sugi Predict / Compounds / SCHEMBL891396

SCHEMBL891396

SCHEMBL891396

CC(=O)OC1C(C)(C)[C@@H]2CC[C@@]1(C)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ GPR84 Q9NQS5 1/20 0.51
▸ CTSV O60911 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ CTSS P25774 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ SCN9A Q15858 1/20 0.37
▸ TAS1R3 Q7RTX0 2/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ TAS1R2 Q8TE23 1/20 0.35
▸ ALOX15 P16050 1/20 0.33
▸ APP P05067 4/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18076323 1.00 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL184488 1.00 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL14867336 1.00 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL901146 1.00 CYP3A4 (0.55) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
Acetic Acid SCHEMBL17748827 0.96 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL25383430 0.87 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL20722267 0.87 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL20722270 0.85 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL10660858 0.85 CYP3A4 (0.58) CYP3A4CYP2D6CYP2C9CYP2C19TDP1
SCHEMBL17338713 0.83 CYP3A4 (0.43) CYP3A4CYP2D6CYP2C9CYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1894603-B1 Encapsulation of bulky fragrance molecules TAKASAGO PERFUMERY CO LTD (JP) 2014-11-19 — — EP claimed
CN-122034090-A Original-flavor cedar fragrance releasing plate and preparation method and application thereof 北京林业大学 2026-05-15 — — CN disclosed
US-12577511-B2 Agent containing emulsifier and microcapsules HENKEL AG & CO. KGAA (DE) 2026-03-17 — — US disclosed
US-12508218-B2 Coating compositions COTY INC. (US) 2025-12-30 — — US disclosed
EP-3103523-B1 ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION PROCTER & GAMBLE (US) 2025-10-29 — — EP disclosed
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF COTY INC. 2025-05-15 — — US disclosed
US-20250127707-A1 FRAGRANCE FORMULATION COTY INC. 2025-04-24 — — US disclosed
US-12178896-B2 Fragrance compositions and uses thereof COTY INC. (US) 2024-12-31 — — US disclosed
US-20240287420-A1 COMPOSITIONS CONTAINING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2024-08-29 — — US disclosed
EP-3215231-B2 CAPSULE COMPOSITION GIVAUDAN SA (CH) 2024-07-31 — — EP disclosed
US-20090281195-A1 NOVEL COCRYSTALLIZATION S.S.C.I., INC. (US) 2009-11-12 — — US disclosed
US-7538079-B2 Spray dried powdered detergents with perfume-containing capsules TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-05-26 — — US disclosed
US-7452555-B2 Cocrystallization S.S.C.I., INC. (US) 2008-11-18 — — US disclosed
US-20080176780-A1 ENCAPSULATION OF BULKY FRAGRANCE MOLECULES TAKASAGO INTERNATIONAL CORPORATION (JP) 2008-07-24 — — US disclosed
EP-1894603-A1 Encapsulation of bulky fragrance molecules Takasago International Corporation (JP) 2008-03-05 — — EP disclosed
US-20070287194-A1 Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound S.S.C.I., INC 2007-12-13 — — US disclosed
US-20070149423-A1 Spray drying TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-28 — — US disclosed
US-20070088508-A1 Cocrystallization methods APTUIT (WEST LAFAYETTE), LLC 2007-04-19 — — US disclosed
EP-1767614-A1 Process for the manufacture of a spray dried powder Takasago International Corporation (JP) 2007-03-28 — — EP disclosed
EP-1767613-A1 Process for the manufacture of a spray dried powder Takasago International Corporation (JP) 2007-03-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12178896-B2 Fragrance compositions and uses thereof FHIT, ALG3, FEM1B CYP3A4 1548/4885CYP2D6 2752/4885CYP2C9 1590/4885
US-12577511-B2 Agent containing emulsifier and microcapsules LIPA, CUTA, MGLL CYP3A4 2465/4885CYP2D6 2613/4885CYP2C9 1061/4885
US-20250127707-A1 FRAGRANCE FORMULATION PUF60, POLM, ADH5 CYP3A4 973/4885CYP2D6 2219/4885CYP2C9 1305/4885
US-20240287420-A1 COMPOSITIONS CONTAINING COLOUR-NEUTRAL DEGRADABLE MICROCAPSULES LIPA, CUTA, MGLL CYP3A4 4095/4885CYP2D6 3811/4885CYP2C9 2686/4885
US-12508218-B2 Coating compositions TAS2R40, TAS2R20, TAS2R10 CYP3A4 1938/4885CYP2D6 2452/4885CYP2C9 1376/4885
US-20250152487-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF FHIT, ALG3, FEM1B CYP3A4 1548/4885CYP2D6 2752/4885CYP2C9 1590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.